ArticleDrug metabolism and disposition: the biological fate of chemicals2025
Organic cation transporter 1 and cytochrome P450s play crucial roles in coptisine- and worenine-induced hepatotoxicity.
Article in Drug metabolism and disposition: the biological fate of chemicals, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coptisine and worenine, isoquinoline alkaloids prevalent in traditional herbal medicines from Papaveraceae (eg, Corydalis Rhizoma) and Ranunculaceae (eg, Coptidis Rhizoma), exhibit significant pharmacologic effects, including cardioprotective and anticancer properties. However, little information is available concerning coptisine- or worenine-induced toxicity, particularly hepatotoxicity, and the underlying mechanisms. Coptisine and worenine contain methylenedioxyphenyl groups, which may be metabolized by cytochrome P450s (P450s) to form reactive metabolites and subsequently induce toxicity. In this study, we demonstrated coptisine- and worenine-induced hepatotoxicity in vitro (in primary mouse and human hepatocytes) and in vivo (in mice). We also found that coptisine and worenine showed significant hepatic accumulation, likely caused by organic cation transporter 1 (OCT1)-mediated uptake, outweighing multidrug and toxin extrusion 1 (MATE1)-mediated efflux, consistent with the higher expression level of OCT1 relative to MATE1. Furthermore, P450s, including CYP1A2, CYP2D6, and CYP3A4, contributed to the formation of reactive quinone-like metabolites (M1 from coptisine and M2, M3, and M4 from worenine), subsequently leading to hepatotoxicity. Additionally, uridine diphosphate glycosyltransferases (UGTs) attenuated coptisine- or worenine-induced hepatocyte toxicity by reducing the formation of reactive metabolites. In conclusion, the present study demonstrated that OCT1 and P450s play crucial roles in coptisine- and worenine-induced hepatotoxicity and that UGTs alleviate the hepatotoxicity. This study provides critical evidence for the safe use of coptisine, worenine, and related traditional Chinese medicines or natural products containing these compounds. SIGNIFICANCE STATEMENT: Coptisine and worenine, bioactive isoquinoline alkaloids from traditional herbs, induce hepatotoxicity via organic cation transporter 1-driven hepatic accumulation and CYP1A2/2D6/3A4-mediated metabolic activation. Our findings underscore the importance of transport- and metabolism-guided safety evaluations of herbal medicines containing these compounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.